vimarsana.com
Home
Live Updates
Safety and Clinical Experience of XPO1 Inhibitors in R/R MM Patients : vimarsana.com
Safety and Clinical Experience of XPO1 Inhibitors in R/R MM Patients
Dr. Usmani, MD, MBA, FACP provides insights into Selinexor's safety profile in Relapsed/Refractory Multiple Myeloma (R/R MM), comparing it with other treatments and delve into the ongoing challenges and unmet needs in R/R MM patient care.
Related Keywords
,
Clinical Experience ,
Refractory Multiple Myeloma ,
Myeloma ,
Multiple Myeloma ,
Xpo1 Inhibitors ,
Rapid Readouts ,
Evolving Role Of Xpo1 Inhibitors In Multiple Myeloma ,
Xp01 ,
Xpo1 ,
vimarsana.com © 2020. All Rights Reserved.